S M Levitz

632 total citations
11 papers, 498 citations indexed

About

S M Levitz is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, S M Levitz has authored 11 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 6 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in S M Levitz's work include Fungal Infections and Studies (9 papers), Antifungal resistance and susceptibility (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). S M Levitz is often cited by papers focused on Fungal Infections and Studies (9 papers), Antifungal resistance and susceptibility (5 papers) and Toxin Mechanisms and Immunotoxins (4 papers). S M Levitz collaborates with scholars based in United States and United Kingdom. S M Levitz's co-authors include Maxime Dupont, David DiBenedetto, A Tabuni, Richard T. Maziarz, Herbert L. Mathews, J W Murphy, Hardy Kornfeld, Eleftherios Mylonakis, Asako Chiba and Beth Burgwyn Fuchs and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and The Journal of Infectious Diseases.

In The Last Decade

S M Levitz

11 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S M Levitz United States 9 356 248 243 37 32 11 498
A Tabuni United States 8 330 0.9× 145 0.6× 265 1.1× 23 0.6× 37 1.2× 9 431
Wendy Chaka Netherlands 8 235 0.7× 110 0.4× 169 0.7× 26 0.7× 36 1.1× 10 336
Celidéia Aparecida Coppi Vaz Brazil 14 637 1.8× 173 0.7× 450 1.9× 43 1.2× 65 2.0× 24 705
Natalia Castro-Lopez United States 11 275 0.8× 214 0.9× 219 0.9× 26 0.7× 80 2.5× 19 471
J Oberti France 6 190 0.5× 98 0.4× 233 1.0× 21 0.6× 47 1.5× 16 400
Kevin C. Yim United States 13 522 1.5× 173 0.7× 335 1.4× 18 0.5× 76 2.4× 24 685
Carolyn Saylor United States 6 160 0.4× 156 0.6× 137 0.6× 26 0.7× 109 3.4× 6 411
Sean K. Bauman United States 8 488 1.4× 44 0.2× 443 1.8× 37 1.0× 32 1.0× 8 556
R Turcotte Canada 13 257 0.7× 257 1.0× 292 1.2× 14 0.4× 67 2.1× 44 560
Lang Bao China 13 203 0.6× 145 0.6× 309 1.3× 10 0.3× 101 3.2× 42 424

Countries citing papers authored by S M Levitz

Since Specialization
Citations

This map shows the geographic impact of S M Levitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S M Levitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S M Levitz more than expected).

Fields of papers citing papers by S M Levitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S M Levitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S M Levitz. The network helps show where S M Levitz may publish in the future.

Co-authorship network of co-authors of S M Levitz

This figure shows the co-authorship network connecting the top 25 collaborators of S M Levitz. A scholar is included among the top collaborators of S M Levitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S M Levitz. S M Levitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Cohen, Nadia, Raju V. V. Tatituri, Amariliz Rivera, et al.. (2011). Innate Recognition of Cell Wall β-Glucans Drives Invariant Natural Killer T Cell Responses against Fungi. Cell Host & Microbe. 10(5). 437–450. 88 indexed citations
2.
Levitz, S M, A Tabuni, Thomas R. Kozel, et al.. (1997). Binding of Cryptococcus neoformans to heterologously expressed human complement receptors. Infection and Immunity. 65(3). 931–935. 24 indexed citations
3.
Levitz, S M, Herbert L. Mathews, & J W Murphy. (1995). Direct antimicrobial activity of T cells. Immunology Today. 16(8). 387–391. 37 indexed citations
4.
Levitz, S M, et al.. (1994). Direct activity of human T lymphocytes and natural killer cells against Cryptococcus neoformans. Infection and Immunity. 62(1). 194–202. 99 indexed citations
5.
Levitz, S M & Maxime Dupont. (1993). Phenotypic and functional characterization of human lymphocytes activated by interleukin-2 to directly inhibit growth of Cryptococcus neoformans in vitro.. Journal of Clinical Investigation. 91(4). 1490–1498. 68 indexed citations
6.
Levitz, S M, et al.. (1993). Effect of mannose-binding protein on binding of Cryptococcus neoformans to human phagocytes. Infection and Immunity. 61(11). 4891–4893. 24 indexed citations
7.
Levitz, S M, et al.. (1992). Binding of Unopsonized Cryptococcus neoformans by Human BronchoalveolarMacrophages: Inhibition by a Large-Molecular-Size Serum Component. The Journal of Infectious Diseases. 166(4). 866–873. 5 indexed citations
8.
Levitz, S M, et al.. (1992). HIV-1 Envelope Protein (gp120) Inhibits the Activity of Human Bronchoalveolar Macrophages against Cryptococcus neoformans. American Review of Respiratory Disease. 146(6). 1434–1438. 30 indexed citations
9.
Levitz, S M, et al.. (1991). Killing of Cryptococcus neoformans by Human Peripheral Blood Mononuclear Cells Stimulated in Culture. The Journal of Infectious Diseases. 163(5). 1108–1113. 48 indexed citations
10.
Levitz, S M. (1989). Aspergillosis.. PubMed. 3(1). 1–18. 5 indexed citations
11.
Levitz, S M & David DiBenedetto. (1989). Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.. The Journal of Immunology. 142(2). 659–665. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026